Sanofi

Sanofi Pharmaceuticals – Product Catalog (A–Z)

Aldurazyme → Generic: laronidase (enzyme replacement) → Indication: Mucopolysaccharidosis I (Hurler, Hurler-Scheie) → Dose: IV infusion 100 U/mL

Amaryl → Generic: glimepiride → Indication: Type 2 diabetes (sulfonylurea) → Dose: Tablets 1–4 mg

Aprovel / Avapro → Generic: irbesartan → Indication: Hypertension, diabetic nephropathy → Dose: Tabs 75–300 mg

Apidra → Generic: insulin glulisine → Indication: Diabetes mellitus (rapid-acting insulin) → Dose: Vials/pens 100 U/mL

Aubagio → Generic: teriflunomide → Indication: Relapsing multiple sclerosis (MS) → Dose: Tablets 7 mg, 14 mg

Cablivi → Generic: caplacizumab → Indication: Acquired thrombotic thrombocytopenic purpura (aTTP) → Dose: SC injection 10 mg

Caprelsa → Generic: vandetanib → Indication: Medullary thyroid carcinoma → Dose: Tablets 100 mg, 300 mg

ClikSTAR / SoloSTAR (devices) → Generic: insulin delivery pens → Indication: Insulin-dependent diabetes → Dose: Prefilled pens (used for Lantus, Apidra, Toujeo)

Clexane / Lovenox → Generic: enoxaparin sodium → Indication: Anticoagulation (VTE, DVT, ACS) → Dose: Prefilled syringes 20–100 mg

Dupixent → Generic: dupilumab → Indication: Atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis → Dose: Prefilled syringe/pen 200–300 mg SC

Eloxatin → Generic: oxaliplatin → Indication: Colorectal cancer (FOLFOX regimen) → Dose: IV infusion 50–200 mg vials

Fabrazyme → Generic: agalsidase beta → Indication: Fabry disease → Dose: IV infusion 1 mg/kg every 2 weeks

Fasturtec / Elitek → Generic: rasburicase → Indication: Tumor lysis syndrome (TLS) → Dose: IV infusion 1.5 mg/mL

Fluzone / Vaxigrip → Generic: influenza vaccine → Indication: Influenza prevention → Dose: IM injection, quadrivalent/trivalent formulations

Genvisc / Synvisc → Generic: hylan G-F 20 → Indication: Osteoarthritis knee pain (viscosupplement) → Dose: Intra-articular injection 16 mg/2 mL, 48 mg/6 mL

Jefferex (regional) → Generic: ferrous sulfate formulations → Indication: Iron-deficiency anemia → Dose: Syrup/tablets

Kevzara → Generic: sarilumab → Indication: Rheumatoid arthritis → Dose: Prefilled syringe/pen 150–200 mg SC

Lantus → Generic: insulin glargine (long-acting) → Indication: Diabetes mellitus → Dose: Vials/pens 100 U/mL

Lemtrada → Generic: alemtuzumab → Indication: Relapsing multiple sclerosis → Dose: IV infusion 12 mg/day × 5 days, then yearly

Multaq → Generic: dronedarone → Indication: Atrial fibrillation/flutter → Dose: Tablets 400 mg bid

Myozyme / Lumizyme → Generic: alglucosidase alfa → Indication: Pompe disease (enzyme replacement) → Dose: IV infusion 20 mg/kg q2w

Ozurdex (co-promoted) → Generic: dexamethasone intravitreal implant → Indication: Macular edema, uveitis → Dose: Biodegradable implant 0.7 mg

Plavix → Generic: clopidogrel bisulfate → Indication: Antiplatelet (ACS, MI, stroke prevention) → Dose: Tablets 75 mg, 300 mg

Praluent → Generic: alirocumab → Indication: Hypercholesterolemia (PCSK9 inhibitor) → Dose: Prefilled pens 75 mg, 150 mg SC q2w

Renvela → Generic: sevelamer carbonate → Indication: Hyperphosphatemia in CKD → Dose: Tablets 800 mg; powder packets

Suliqua → Generic: insulin glargine + lixisenatide → Indication: Type 2 diabetes → Dose: Prefilled pen (100 U/33 mcg per mL)

Toujeo → Generic: insulin glargine (U-300 formulation) → Indication: Diabetes mellitus → Dose: Prefilled pens 300 U/mL

Thymoglobulin → Generic: antithymocyte globulin (rabbit) → Indication: Transplant rejection prophylaxis & treatment → Dose: IV infusion vials 25 mg

Targretin → Generic: bexarotene → Indication: Cutaneous T-cell lymphoma (CTCL) → Dose: Caps 75 mg; topical gel 1%

Taxotere → Generic: docetaxel → Indication: Breast, lung, prostate, gastric cancers → Dose: IV infusion vials 20–160 mg

Zaltrap → Generic: ziv-aflibercept → Indication: Metastatic colorectal cancer (with FOLFIRI) → Dose: IV infusion 25 mg/mL

Zovirax → Generic: acyclovir → Indication: Herpes simplex, shingles → Dose: Tabs 200–800 mg; cream 5%; IV